[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HU177970B - Process for producing new glucosamine derivatives - Google Patents

Process for producing new glucosamine derivatives

Info

Publication number
HU177970B
HU177970B HU76CI1702A HUCI001702A HU177970B HU 177970 B HU177970 B HU 177970B HU 76CI1702 A HU76CI1702 A HU 76CI1702A HU CI001702 A HUCI001702 A HU CI001702A HU 177970 B HU177970 B HU 177970B
Authority
HU
Hungary
Prior art keywords
producing new
glucosamine derivatives
new glucosamine
derivatives
producing
Prior art date
Application number
HU76CI1702A
Other languages
English (en)
Inventor
Gerhard Baschang
Albert Hartmann
Jaroslaw Stanek
Alex Sele
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of HU177970B publication Critical patent/HU177970B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU76CI1702A 1975-12-10 1976-12-09 Process for producing new glucosamine derivatives HU177970B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1604275A CH613709A5 (en) 1975-12-10 1975-12-10 Process for the preparation of glucosamine derivatives

Publications (1)

Publication Number Publication Date
HU177970B true HU177970B (en) 1982-02-28

Family

ID=4414012

Family Applications (1)

Application Number Title Priority Date Filing Date
HU76CI1702A HU177970B (en) 1975-12-10 1976-12-09 Process for producing new glucosamine derivatives

Country Status (30)

Country Link
JP (1) JPS5273820A (hu)
AR (2) AR224091A1 (hu)
AT (1) AT365607B (hu)
AU (1) AU508764B2 (hu)
BE (1) BE849214A (hu)
CA (1) CA1262400A (hu)
CH (2) CH613709A5 (hu)
CS (4) CS205027B2 (hu)
DD (1) DD129781A5 (hu)
DE (1) DE2655500A1 (hu)
DK (1) DK154654C (hu)
ES (2) ES454118A1 (hu)
FI (1) FI64164C (hu)
FR (1) FR2361902A1 (hu)
GB (1) GB1570625A (hu)
GR (1) GR61647B (hu)
HK (1) HK32883A (hu)
HU (1) HU177970B (hu)
IE (1) IE44190B1 (hu)
IL (1) IL51076A (hu)
MY (1) MY8400123A (hu)
NL (1) NL7613666A (hu)
NO (1) NO144850C (hu)
NZ (1) NZ182837A (hu)
PL (4) PL110353B1 (hu)
PT (1) PT65946B (hu)
SE (1) SE445923B (hu)
SG (1) SG11083G (hu)
SU (3) SU660589A3 (hu)
ZA (1) ZA767333B (hu)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
US4370265A (en) * 1974-10-22 1983-01-25 Agence Nationale De Valorisation Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
GB1571133A (en) * 1976-04-26 1980-07-09 Syntex Inc Immuniological adjuvant peptidoglycans compounds and methods of preparation thereof
EP0002677B1 (en) 1977-12-02 1982-10-13 Takeda Chemical Industries, Ltd. Glucosamine-peptide derivatives and their pharmaceutical compositions
CA1138436A (en) * 1978-02-24 1982-12-28 Gerhard Baschang Process for the manufacture of novel antigens
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
FR2420545A1 (fr) * 1978-03-20 1979-10-19 Anvar Nouveaux esters de l'acide n-acetyl-muramyl-aminoacyl-glutamique ou des derives de substitution de celui-ci a proprietes anti-infectieuses et/ou d'adjuvants immunologiques
FR2442241A2 (fr) * 1978-03-20 1980-06-20 Anvar Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes
FR2428050A1 (fr) * 1978-06-05 1980-01-04 Anvar Oligomeres de composes du type muramyl-peptide et medicaments les contenant
FR2428051A1 (fr) * 1978-06-05 1980-01-04 Anvar Nouveaux composes du type muramyl-peptide et medicaments les contenant
FR2446292A1 (fr) * 1979-01-12 1980-08-08 Anvar Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant
US4256735A (en) * 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation
FR2449697A1 (fr) 1979-02-20 1980-09-19 Anvar Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant
JPS55111499A (en) * 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
JPS5618996A (en) * 1979-06-21 1981-02-23 Dai Ichi Seiyaku Co Ltd Muramyldipeptide derivative
FI75578C (fi) 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
JPS5649396A (en) * 1979-09-28 1981-05-02 Dai Ichi Seiyaku Co Ltd Novel muramyldipeptide derivative
DE3070457D1 (en) * 1979-10-02 1985-05-15 Ciba Geigy Ag Combinatory compositions for use in a method for enhancing the activity of antibiotics, antibiotic preparations having enhanced activity and process for their production
FI803077A (fi) 1979-10-12 1981-04-13 Ciba Geigy Ag Foerfarande foer framstaellning av myramylpeptider
US4409209A (en) * 1979-10-12 1983-10-11 Ciba-Geigy Corporation Novel phosphorylmuramyl peptides and processes for the manufacture thereof
US4406889A (en) * 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
US4310514A (en) 1980-05-05 1982-01-12 Merck & Co., Inc. Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation
EP0056560A1 (de) * 1981-01-19 1982-07-28 Ciba-Geigy Ag Antibiotische Präparate mit gesteigerter Wirksamkeit, Verfahren zu deren Herstellung und Verfahren zur Steigerung der antibiotischen Wirkung von Antibiotika
GR78246B (hu) * 1981-01-23 1984-09-26 Ciba Geigy Ag
JPS6042398A (ja) * 1983-08-18 1985-03-06 Toshiyuki Hamaoka ムラミルジペプチド活性エステル誘導体
EP0541486A1 (de) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclische Konjugate
WO2006118327A1 (ja) * 2005-04-27 2006-11-09 Oxygenix Co Ltd カチオン性アミノ酸型脂質
US10610564B2 (en) 2015-02-26 2020-04-07 Stc.Unm IRGM and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
US10927147B2 (en) 2015-12-10 2021-02-23 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof
US12134664B2 (en) 2015-12-10 2024-11-05 Bharat Biotech International Ltd. Muramyl peptide derivatives
EP3389643B1 (en) * 2015-12-15 2023-05-03 Bharat Biotech International Limited Novel muramyl peptide derivative compound, synthesis and uses thereof
EP3672939A1 (en) 2017-08-21 2020-07-01 Celgene Corporation Processes for preparation of (s)-tert-butyl 4,5-diamino-5-oxopentanoate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents

Also Published As

Publication number Publication date
DK154654B (da) 1988-12-05
PL194291A1 (pl) 1978-10-23
PT65946B (en) 1978-06-14
HK32883A (en) 1983-09-02
BE849214A (fr) 1977-06-09
SG11083G (en) 1983-09-16
FI763541A (hu) 1977-06-11
ATA909276A (de) 1981-06-15
IE44190L (en) 1977-06-10
DE2655500A1 (de) 1977-06-23
FR2361902B1 (hu) 1980-11-07
JPS5273820A (en) 1977-06-21
ES465514A1 (es) 1978-09-16
CS205026B2 (en) 1981-04-30
PL112672B1 (en) 1980-10-31
CA1262400A (en) 1989-10-17
NO144850C (no) 1981-11-25
PT65946A (en) 1977-01-01
NO144850B (no) 1981-08-17
CS205028B2 (en) 1981-04-30
PL110794B1 (en) 1980-07-31
FR2361902A1 (fr) 1978-03-17
SU660589A3 (ru) 1979-04-30
JPS638118B2 (hu) 1988-02-19
CH613709A5 (en) 1979-10-15
PL110353B1 (en) 1980-07-31
DE2655500C2 (hu) 1988-12-22
IE44190B1 (en) 1981-09-09
AR224091A1 (es) 1981-10-30
AR220686A1 (es) 1980-11-28
ZA767333B (en) 1977-11-30
CH614718A5 (en) 1979-12-14
DK154654C (da) 1989-05-08
FI64164C (fi) 1983-10-10
NO764191L (hu) 1977-06-13
IL51076A (en) 1980-09-16
CS205027B2 (en) 1981-04-30
PL110787B1 (en) 1980-07-31
SE7613851L (sv) 1977-06-11
CS205025B2 (en) 1981-04-30
DK552476A (da) 1977-06-11
AU2042276A (en) 1978-06-15
FI64164B (fi) 1983-06-30
NL7613666A (nl) 1977-06-14
MY8400123A (en) 1984-12-31
ES454118A1 (es) 1978-03-01
SU747430A3 (ru) 1980-07-23
NZ182837A (en) 1978-07-28
GB1570625A (en) 1980-07-02
GR61647B (en) 1978-12-05
AT365607B (de) 1982-02-10
DD129781A5 (de) 1978-02-08
IL51076A0 (en) 1977-02-28
SE445923B (sv) 1986-07-28
AU508764B2 (en) 1980-04-03
SU1060118A3 (ru) 1983-12-07

Similar Documents

Publication Publication Date Title
HU177970B (en) Process for producing new glucosamine derivatives
HU172929B (hu) Sposob poluchenija proizvodnykh pirido-pirimido- ili tiazolo-kinazolinov
HU178128B (en) Process for producing corticosteroides
HU175186B (hu) Sposob poluchenija novykh proizvodnykh eritromicina
HU174850B (hu) Sposob poluchenija slozhnykh 17-al'fa-efirov 21-galogeno-pregnanov
HU175369B (hu) Sposob poluchneija novykh proizvodnykh 16-degidro-androstana
HU173693B (hu) Sposob poluchenija zamehhennykh proizvodnykh tieno-benzodiazepina
HU172483B (hu) Sposob poluchenija benzimidazol-karbamatov
HU175175B (hu) Sposob poluchenija novykh proizvodnykh butirofenona
HU172452B (hu) Sposob poluchenija propargil-2-fenilamino-2-imidazolinov
HU174191B (hu) Sposob poluchenija soedinenijj acilamino-oksadiazola i -tiadiazola
HU175289B (hu) Sposob poluchenija proizvodnykh aminobenzociklogeptena
HU171083B (hu) Sposob poluchenija l-3-skobka-3-zapjataja vverkh-zapjataja vniz-4-zapjataja vverkh-digidroksi-fenil-skobka zakryta-2-metil-alanin-peptidov
HU172441B (hu) Sposob poluchenija omega-skobka-arilsul'fonamido-skobka
HU175422B (hu) Sposob poluchenija novykh proizvodnykh 11-okso-prostaglandinov
HU178337B (en) Process for producing chlorothioformic acid-ethyl-esters
HU173926B (hu) Sposob poluchenija 3-fenoksi-benzaldehidov
HU172026B (hu) Sposob poluchenija slozh nykh efirov alkanolov i 1-skobka-1-fenil-etil-skobka zakryta-1h-imidazol-5-karbonovojj kisloty
HU174587B (hu) Sposob poluchenija proizvodnykh tiazolidinov
HU172729B (hu) Sposob poluchenija novykh cefem-soedinenijj
HU171663B (hu) Sposob poluchenija novykh proizvodnykh 14-skobka-zamehhennogo metil-skobka zakryta-vinkana
HU172481B (hu) Sposob poluchenija 2-alkil-indanov
HU175158B (hu) Sposob poluchenija proizvodnykh naftacena
HU172549B (hu) Sposob poluchenija proizvodnykh 3-tetrazolil-gamma-kromona
HU173348B (hu) Sposob poluchenija novykh proizvodnykh 8-aza-prostaglandinov